Skip to main content

The Rules Governing Medicinal Products for Human Use in the European Union

  • Chapter
Technetium-99m Pharmaceuticals

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 139.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 179.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • European Commission (2003 a) Detailed guidance for the request for authorization of a clinical trial on a medicinal product for human use to the competent authorities, notification of substantial amendments and declaration of the end of the trial. (http://pharmacos.eudra.org/F2/pharmacos/docs/Doc2005/10_05/CA_14-2005.pdf)

    Google Scholar 

  • European Commission (2003 b) Detailed guidance on the European clinical trials database (EudraCT Database). http://pharmacos.eudra.org/F2/pharmacos/docs/Doc2003/april/cp-guidance-eudract_230403.pdf)

    Google Scholar 

  • European Commission (2005) Commission Directive 2005/28/EC of 8 April 2005 laying down principles and detailed guidelines for good clinical practice as regards investigational medicinal products for human use, as well as the requirements for authorisation of the manufacturing or importation of such products.

    Google Scholar 

  • European Medicines Agency (2004) CPMP/CHMP/QWP185401 Draft guideline on the requirements to the chemical and pharmaceutical quality documentation concerning investigational medicinal products in clinical trials. (http://www.emea.eu.int/Inspections/docs/18540104en.pdf)

    Google Scholar 

  • European Parliament and the Council of the European Union (2001) Directive 2001/20/EC of the European Parliament and of the Council of 4 April 2001 on the approximation of the laws, regulations and administrative provisions of the Member States relating to the implementation of good clinical practice in the conduct of clinical trials on medicinal products for human use. (http://pharmacos.eudra.org/F2/eudralex/vol-l/DIR_2001_20/DIR_2001_20_EN.pdf)

    Google Scholar 

  • Kristensen K (1979) Preparation and control of radiopharmaceuticals in hospitals. Technical Reports Series No. 194. International Atomic Energy Agency, Vienna

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2007 Springer Berlin Heidelberg

About this chapter

Cite this chapter

Verbruggen, A., Zolle, I. (2007). The Rules Governing Medicinal Products for Human Use in the European Union. In: Zolle, I. (eds) Technetium-99m Pharmaceuticals. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-33990-8_11

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-33990-8_11

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-33989-2

  • Online ISBN: 978-3-540-33990-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics